Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acasti Pharma Inc (NASDAQ:ACST)

1.29
Delayed Data
As of 2:24pm ET
 -0.05 / -3.73%
Today’s Change
1.11
Today|||52-Week Range
3.09
+3.20%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$19.7M

Company Description

Acasti Pharma, Inc. engages in the research, development, and commercialization of krill oil-based forms of omega-3 phospholipid therapies. It seeks to treat certain cardiometabolic disorders such as abnormalities in blood lipids, also known as dyslipidemia. It sproduct candidate, CaPre, is being developed to treat severe hypertriglyceridemia. The company was founded by Henri Harland on February 1, 2002 and is headquartered in Laval, Canada.

Contact Information

Acasti Pharma, Inc.
545 Promenade du Centropolis
Laval Quă©bec H7T 0A3
P:(450) 686-4555
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Janelle D'AlvisePresident, Chief Executive Officer & Director
Pierre LemieuxChief Operating Officer
Linda P. O'KeefeChief Financial Officer
Laurent HarveyVice President-Clinical & Non-Clinical Affairs
Jean-Daniel BĂ©langerSecretary